IRIS
ORIO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.950
NA - Nord America 3.523
EU - Europa 2.479
SA - Sud America 490
AF - Africa 124
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 2
Totale 10.573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.382
SG - Singapore 1.671
RU - Federazione Russa 1.285
CN - Cina 814
VN - Vietnam 797
BR - Brasile 396
HK - Hong Kong 323
IT - Italia 218
DE - Germania 200
NL - Olanda 149
FI - Finlandia 124
FR - Francia 120
IE - Irlanda 104
SE - Svezia 81
CA - Canada 75
GB - Regno Unito 69
IN - India 61
JP - Giappone 60
MX - Messico 40
AR - Argentina 38
CI - Costa d'Avorio 36
UA - Ucraina 35
BD - Bangladesh 28
IQ - Iraq 27
PL - Polonia 25
ZA - Sudafrica 25
ES - Italia 23
PH - Filippine 23
EC - Ecuador 18
KR - Corea 17
TR - Turchia 17
ID - Indonesia 15
PK - Pakistan 15
DZ - Algeria 14
TH - Thailandia 14
LT - Lituania 12
CZ - Repubblica Ceca 11
PY - Paraguay 9
TW - Taiwan 9
TN - Tunisia 8
EG - Egitto 7
UZ - Uzbekistan 7
BE - Belgio 6
CL - Cile 6
CO - Colombia 6
DO - Repubblica Dominicana 6
JO - Giordania 6
KE - Kenya 6
NP - Nepal 6
JM - Giamaica 5
KZ - Kazakistan 5
SA - Arabia Saudita 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
GE - Georgia 4
MA - Marocco 4
NG - Nigeria 4
PE - Perù 4
UY - Uruguay 4
VE - Venezuela 4
AZ - Azerbaigian 3
ET - Etiopia 3
KG - Kirghizistan 3
MU - Mauritius 3
MW - Malawi 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AT - Austria 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
LB - Libano 2
LC - Santa Lucia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
RS - Serbia 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CD - Congo 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
Totale 10.562
Salva come PNG Salva come JPEG
Città #
Singapore 762
San Jose 613
Hong Kong 310
Moscow 310
Beijing 302
Chandler 297
Ashburn 238
Ho Chi Minh City 222
Hanoi 185
Amsterdam 137
Millbury 133
Santa Clara 114
Los Angeles 113
Princeton 101
The Dalles 97
Lauterbourg 94
Naples 92
Nanjing 88
Jacksonville 75
Munich 71
New York 56
Boston 49
Tokyo 49
Wilmington 49
São Paulo 46
Dallas 45
Dong Ket 40
Buffalo 39
Seattle 38
Nanchang 36
Redondo Beach 36
Orem 31
Council Bluffs 30
Da Nang 30
Ottawa 27
Des Moines 26
Napoli 26
Helsinki 25
Mexico City 24
Chennai 23
Haiphong 23
Chicago 21
Atlanta 20
Denver 20
Montreal 20
Stockholm 20
Phoenix 17
Shenyang 17
Warsaw 17
Turku 16
Frankfurt am Main 15
Tianjin 15
Brooklyn 14
Hải Dương 14
Jiaxing 14
Falkenstein 13
Hebei 13
Johannesburg 13
London 13
Norwalk 13
Biên Hòa 12
Changsha 12
Houston 12
Rio de Janeiro 12
Toronto 12
Dublin 11
Poplar 11
Woodbridge 11
Can Tho 10
Dearborn 9
Falls Church 9
San Francisco 9
Boardman 8
Guangzhou 8
Nha Trang 8
Redwood City 8
Rome 8
Shanghai 8
Thái Bình 8
Brno 7
Düsseldorf 7
Guayaquil 7
Kunming 7
Madrid 7
Manchester 7
Nuremberg 7
Phủ Lý 7
Pune 7
Ankara 6
Brasília 6
Hefei 6
Milan 6
São José do Rio Preto 6
Thái Nguyên 6
Algiers 5
Amman 5
Bình Phước 5
Curitiba 5
Guarulhos 5
Jakarta 5
Totale 5.722
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 178
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 160
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 158
Influence of nutrition on somatotropic axis: Milk consumption in adult individuals with moderate-severe obesity 157
Cardiopulmonary impairment in young women with polycystic ovary syndrome 152
BISPHENOL A IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH LIVER-SPLEEN AXIS. 151
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 151
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 150
Endocrine Aspects of Environmental "Obesogen" Pollutants 149
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 143
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 141
Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome 141
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 140
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 138
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison 138
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 134
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 133
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 133
Effects of neridronate treatment in elderly women with osteoporosis 132
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors. 131
Lifestyle changes in the management of adulthood and childhood obesity. 131
Vitamin D and chronic diseases: the current state of the art 131
Evidence for altered adipocyte function in polycystic ovary syndrome 129
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 129
Low vitamin D status and obesity: Role of nutritionist 129
Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420-1426 129
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 128
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 128
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 126
Cardiovascular complications of obesity in adolescents 126
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 126
Adrenocortical tumors and insulin resistance: What is the first step? 126
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 125
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 124
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 124
Vitamin D and thyroid disease: To D or not to D? 124
Metabolic and cardiovascular consequences of polycystic ovary syndrome 123
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 123
THE GOOD AND BAD EFFECTS OF STATINS ON INSULIN SENSITIVITY AND SECRETION. 120
Failure of long-term therapy with sodium valproate in Cushing's disease. 118
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 118
Mechanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease 118
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 117
Endocrine disorders during the first year after autologous stem-cell transplant 117
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 116
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 116
The integrity of the Growth Hormone and Insuline-like Growth Factor -1 axis as outcome predictor after Laparoscopic Adjustable Silicone Gastric Banding. 115
Gut: A key player in the pathogenesis of type 2 diabetes? 115
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 114
Cardiovascular risk in women with polycystic ovary sydrome 111
Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? 107
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 107
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 105
Effect of growth hormone on cardiac function 103
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 103
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 100
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine 99
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 98
Water intake keeps type 2 diabetes away? Focus on copeptin 96
Polycystic ovary syndrome and obesity: non pharmacological approaches 95
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 91
Tianeptine, an antiserotoninergic drug, increases GHRH release into the hypophyseal portal blood of the sheep 88
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 84
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 81
Androgens in polycystic ovary syndrome: the role of exercise and diet 81
Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome. 80
DAI NUOVI CRITERI DIAGNOSTICI ALLE RECENTI ACQUISIZIONI TERAPEUTICHE DELLA SINDROME DELL’OVAIO POLICISTICO. 80
Nutrition, inflammation and liver-spleen axis 80
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. 78
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 77
Cardiovascular complications of obesity 77
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 76
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 75
Cardiovascular risk in women with polycystic ovary syndrome 75
Serum 25-Hydroxyvitamin D Levels, Phosphoprotein Enriched in Diabetes Gene Product (PED/PEA-15) and Leptin-to-Adiponectin Ratio in Women with PCOS. 75
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 73
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 73
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 73
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 72
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 72
STUDY OF HOMOCYSTEINE LEVELS AND C677T POLYMORPHISM OF MTHFR IN YOUNG WOMEN WITH PCOS. 72
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome 72
LA SINDROME METABOLICA NELLA SINDROME DELL’OVAIO POLICISTICO: IL RUOLO DELL’ESERCIZIO FISICO. 70
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 69
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 69
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 66
L’esercizio fisico nei soggetti obesi. 66
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 63
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. 62
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept 61
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 60
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS) 60
Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome 60
Malattie Ipotalamo Ipofisarie- Tumori ipofisari secernenti 60
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 57
Favourable effects of exercise-based Cardiac Rehabilitation after acute myocardial infarction on left atrial remodeling 56
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 55
Relationships between inflammatory markers, visceral fat and maximal oxygen consumption in women with polycystic ovary syndrome. 54
Letter to the Editor: Vitamin D: A Wonder Drug for the Cure of Type 2 Diabetes? 54
Ovulation induction in women with polycystic ovary syndrome 53
Totale 10.399
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.374
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.374
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202147 0 0 0 0 0 0 0 0 0 0 6 41
2021/2022614 5 3 0 6 4 58 2 11 98 28 126 273
2022/2023728 115 64 22 59 81 60 10 55 92 127 35 8
2023/2024486 24 76 118 15 16 38 3 64 3 4 77 48
2024/20252.676 135 132 29 28 50 157 292 170 174 273 1.013 223
2025/20265.302 603 326 528 532 923 223 695 351 659 367 95 0
Totale 10.670